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Abstract
Background: In the recent years, dramatic increases in HIV transmission among men who have sex with men (MSM) have
been observed in China. Human papillomavirus (HPV) infection related anal cancer is more common among HIV-infected
MSM as compared to the general population. However, HPV infection and anal cytology has been rarely studied in HIV-
infected MSM in China.
Methods: HIV-infected MSM in Beijing, China were invited to participate in this study between January and April 2011. Anal
swabs were collected for examining cytology and HPV genotypes.
Results: Ninety-five eligible participants with complete questionnaire and laboratory data were included in the analyses.
Thirty six of them (37.9%) showed abnormal anal cytology as follows: atypical squamous cells of undetermined significance
(ASC-US) in 19 (20.0%), atypical squamous cells but cannot exclude HSIL (ASC-H) in 1 (1.1%), low-grade squamous
intraepithelial lesion (LSIL) in 15 (15.8%), and high-grade squamous intraepithelial lesion (HSIL) in 1 (1.1%). HPV6 (20.0%),
HPV16 (10.9%), HPV56 (10.9%), HPV52 (9.1%) and HPV39 (9.1%) were observed most frequently among those with normal
anal cytology, while different distribution was found in the ones with abnormal anal cytology as HPV6 (19.4%), HPV16
(19.4%), HPV45 (16.7%), HPV52 (16.7%) and HPV18 (11.1%). In addition, HPV16, HPV45, HPV52 and HPV18 were the most
frequent high-risk types in patients with abnormal anal cytology. HPV multiplicity was found to be significantly related to
the prevalence of abnormal anal cytology (p for trend=0.04).
Conclusions: High prevalence of HPV infection and abnormal anal cytology was observed among HIV-infected MSM in
China. Infection of multiple HPV types or high-risk types was found to be associated with an increased risk of abnormal anal
cytology.
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Introduction
While anal carcinoma is rare in the general population [1], it is
more common among men who have sex with men (MSM) [2,3]
and individuals with human immunodeficiency virus (HIV)
infection [4,5]. In the past decades, the incidence of anal cancer
has been increasing in both general MSM and HIV-infected
MSM [6,7]. Screening of anal precancerous lesions in HIV-
infected MSM has been suggested to be important for cancer
prevention [8]. In China, dramatic increases in HIV transmission
among MSM have been observed in recent years. MSM
accounted for nearly one-third of new HIV infections in 2009
[9]. Anal screening should be attached importance to this high-risk
population. Unfortunately, high-resolution anoscopy is still a
resource that is both costly and difficultly to access for HIV-
infected MSM in China at present. Anal cytology, despite of its
high sensitivity and low specificity characteristics, should be much
helpful to this target population for monitoring the development of
anal precancerous lesions [10,11].
Human papillomavirus (HPV) infection, especially high-risk
HPV (HR-HPV) viral types such as HPV 16 and HPV 18, is a
significant risk factor for development of anal intraepithelial
neoplasia (AIN) and anal cancer [12,13]. Two recent meta-
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caused by HPV 16 [14,15]. HPV has not only been linked to the
transformation from innocent cervical epithelium into dysplastic
precancerous states known as cervical interstitial neoplasia (CIN),
but has also been associated with the development of anal
squamous intraepithelial lesions (ASIL) [16]. Other risk factors
include: receptive anal intercourse, history of sexually transmitted
disease, number of lifetime sexual partners, HIV status, lower
CD4 cell count, immunosuppression after solid-organ transplan-
tation, and current cigarette smoking [17,18]. Recent studies have
demonstrated that more than 90% of HIV positive MSM were
also infected with HPV [18–21]. This particular group has a very
high risk of developing ASIL and anal cancer [18]. HPV
genotyping and anal cytology are important to assess the risks of
HPV-related anal diseases in high-risk populations. To our
knowledge, this topic has not yet been studied in China. The
objective of this pilot cross-sectional study was to investigate the
prevalence and distribution of HPV genotypes in HIV-infected
MSM with abnormal anal cytology in Beijing, China.
Results
Subject recruitment and characteristics
A total of 98 eligible participants gave consent to be included
into the study. Three of them were exclude in the final data
analysis because of unsatisfactory cytological evaluation. Of the
remaining participants, about three quarters (75.1%) were aged
20–39 years (Table 1). The majority was of Han ethnic (94.7%),
and over half had been educated over 12 years (56.8%). Around
72.6% described themselves as homosexuals, and 85.3% of these
had their first homosexual intercourse at 18 years old or later.
More than half (53.7%) reported a history of sexually transmitted
diseases (STD) other than HIV, and 54.7% were within the first 2
years of their HIV diagnosis. Over sixty (65.3%) of participants
had a recent CD4 cell count between 200 to 500 cells/mL of blood,
and 30.5% participants ever had highly active antiretroviral
therapy (HAART) (Table 1). Forty-nine participants (51.6%) got
positive results in syphilis test. Only three subjects showed
abnormal physical signs related to STD and two of them were
newly diagnosed with anal warts (2.1%).
Association between sociodemographic/sexual factors
and abnormal anal cytology
As shown in Table 2, of the study participants, 37.9% (36/95)
had abnormal anal cytology, 20.0% (19/95) had atypical
squamous cells of undetermined significance (ASC-US), 1.1%
(1/95) with atypical squamous cells but cannot exclude HSIL
(ASC-H), 15.8% (15/95) with low-grade squamous intraepithelial
lesion (LSIL), and 1.1% (1/95) with high-grade squamous
intraepithelial lesion (HSIL). Half of the participants who had
been educated equal to or less than nine years showed abnormal
anal cytology. As the CD4 count (cells/mL of blood) increases,
study participants appear more likely to have normal anal cytology
(,200: 42.9%; 200–500: 54.8%; .500: 78.6%). Among partici-
pants with CD4 count ,200, 57.1% had abnormal anal cytology
and 42.9% had ASIL/ASC-H. Among participants who had ever
received HAART, 48.3% had abnormal anal cytology while only
17.2% had ASIL/ASC-H. Among participants who had been
diagnosed as HIV positive for less than 2 years, 40.4% had
abnormal anal cytology and 23.1% had ASIL/ASC-H. On the
other hand, among participants who had been diagnosed as HIV
positive for more than 3 years, 31.3% had abnormal anal cytology
and no one had ASIL/ASC-H. A higher prevalence of abnormal
anal cytology was observed among those taking receptive anal sex
as a regular homosexual behavior (Table 3 and Table 4). In
addition, a positive history of STD was found to be related with an
increased risk of ASIL/ASC-H (12/19 vs. 4/16, p=0.01) among
those with abnormal anal cytology.
Table 1. Major characteristics of the study participants.
Variables n* %
Total 95 100
Age
#19 years 3 3.2
20–29 years 33 34.7
30–39 years 38 40.4
$40 years 21 22.1
Ethnicity
Han 90 94.7
Others 5 5.3
Education
#9 years 16 16.8
10–12 years 25 26.3
.12 years 54 56.8
Marriage status
Unmarried 57 60.0
Married/divorced/widowed 38 40.0
Self-reported sexual orientation
Homosexual 69 72.6
Bisexual 25 26.3
History of sexual activity with female
No 43 45.3
Yes 52 54.7
History of STD (except HIV)
No 40 42.1
Yes 51 53.7
Time after HIV diagnosis
,2 year 52 54.7
2–3year 27 28.4
.3 years 16 16.8
History of HARRT
No 64 67.4
Yes 29 30.5
Latest CD4 cell count (cells/mL of blood)
#
,200 7 7.4
200–500 62 65.3
.500 14 14.7
Age at the first homosexual act
,18 14 14.7
$18 81 85.3
Abbreviation: HAART=highly active antiretroviral therapy; HIV=human
immunodeficiency virus; STD=sexually transmitted diseases.
*Sum may not always add up to total because of missing data.
#CD4 cell count was measured in the past three months.
doi:10.1371/journal.pone.0035983.t001
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Table 5 shows the distribution of HPV genotypes of the study
participants. Among those with abnormal anal cytology (n=36),
77.8% were positive for at least one of the 26 targeted HPV types,
and 44.4% were infected with multiple HPV type while this
prevalence was only 20% in those with normal anal cytology.
Among 17 participants with ASIL/ASC-H, 87.5% were infected
with at least one type of HPV. The most common types among
those with normal anal cytology were HPV6 (20.0%), HPV16
(10.9%), HPV56 (10.9%), HPV52 (9.1%) and HPV39 (9.1%). For
those with abnormal anal cytology, the most prevalent types were
HPV6 (19.4%), HPV16 (19.4%), HPV45 (16.7%), HPV52
(16.7%) and HPV18 (11.1%) were observed most frequently.
The association between anal HR-HPV infection and anal
cytology result
As shown in Table 6, having a high-risk HPV type infection was
at an increased risk of ASIL/ASC-H with an adjusted odds ratio
(OR) of 2.48 (95% confidence interval (95% CI): 0.68–9.00).
Having a high-risk HPV type infection is associated with a 63%
Table 2. Association between sociodemographics and abnormal anal cytology among study participants.
Variables
Normal
n/N* (%) Abnormal
Total n/N* (%)
ASC-US n/N*
(%) ASIL/ASC-H n/N* (%)
Total 59/95 (62.1) 36/95 (37.9) 19/95 (20.0) 17/95 (17.9)
Age
,20 years 3/3 (100.0) 0/3 (0) 0/3 (0) 0/3 (0)
20–29 years 20/33 (60.6) 13/33 (39.4) 6/33 (18.2) 7/33 (21.2)
30–39 years 20/38 (52.6) 18/38 (47.4) 11/38 (28.9) 7/38 (18.4)
.39 years 16/21 (76.2) 5/21 (23.8) 2/21 (9.5) 3/21 (14.3)
p for difference
# 0.20 0.30 0.94
Ethnicity
Han 56/90 (62.2) 34/90(37.8) 18/90 (20.0) 16/90 (17.8)
Others 3/5 (60.0) 2/5 (40.0) 1/5 (20.0) 1/5 (20.0)
p for difference
# 1.00 1.00 1.00
Education
#9 years 8/16 (50.0) 8/16 (50.0) 5/16 (31.3) 3/16 (18.8)
10–12 years 16/25 (64.0) 9/25 (36.0) 4/25 (16.0) 5/25 (20.0)
.12 years 35/54 (64.8) 19/54 (35.2) 10/54 (18.5) 9/54 (16.7)
p for difference
# 0.55 0.45 0.93
Marriage status
Unmarried 39/57 (68.4) 18/57 (31.6) 9/57 (15.8) 9/57(15.8)
Married/divorced/widowed 20/38 (52.6) 18/38 (47.4) 10/38 (26.3) 8/38 (21.1)
p for difference
# 0.12 0.21 0.51
History of HARRT
No 43/64 (67.2) 21/64 (32.8) 10/64 (15.6) 11/64 (17.2)
Yes 15/29 (51.7) 14/29 (48.3) 9/29 (31.0) 5/29 (17.2)
p for difference
# 0.15 0.09 1.00
Latest CD4 cell count (cells/mL of blood)
1
,200 3/7 (42.9) 4/7 (57.1) 1/7 (14.3) 3/7 (42.9)
200–500 34/62 (54.8) 28/62 (45.2) 16/62 (25.8) 12/62(19.4)
.500 11/14 (78.6) 3/14 (21.4) 2/14 (14.3) 1/14 (7.1)
p for difference
# 0.21 0.60 0.16
Time since HIV diagnosis (years)
,2 31/52 (59.6) 21/52 (40.4) 9/52 (17.3) 12/52 (23.1)
2–3 17/27 (63.0) 10/27 (37.0) 5/27 (18.5) 5/27 (18.5)
.3 11/16 (68.8) 5/16 (31.3) 5/16 (31.3) 0/16 (0)
p for difference
# 0.80 0.46 0.09
Abbreviation: ASCUS=atypical squamous cells of undetermined significance; ASC-H=atypical squamous cells but cannot exclude HSIL; ASIL=anal squamous
intraepithelial lesions; HAART=highly active antiretroviral therapy; HIV=human immunodeficiency virus.
*Sum may not always add up to total because of missing data.
#Participants with normal cytology was treated as control.
1CD4 cell count was measured in the past three months.
HPV and Abnormal Anal Cytology
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35983increased risk of ASC-US (adjusted OR: 1.63; 95% CI: 0.49–
5.43). There was a significant association between HPV
multiplicity and the prevalence of abnormal anal cytology.
Increased risks were observed for subjects carrying more HPV
types (p for trend=0.04). Individuals positive for three or more
HPV types were at a significantly increased risk of abnormal anal
cytology with an adjusted OR of 4.71 (95% CI: 1.02–21.76)
compared to those HPV anal infection negative, these individuals
were also at a high risk of ASIL/ASC-H with an adjusted OR of
7.49 (1.07–52.21).
Table 3. Association between sexual factors and abnormal anal cytology among study participants.
Variables Normal n/N* (%) Abnormal
Total n/N* (%) ASCUS n/N* (%)
ASIL/ASC-H n/N*
(%)
History of STD (except for HIV)
No 24/40 (60.0) 16/40 (40.0) 12/40 (30.0) 4/40 (10.0)
Yes 32/51 (62.7) 19/51 (37.3) 7/51 (13.7) 12/51 (23.5)
p for difference 0.79 0.06 0.09
Number of homosexual partners ever had
,10 21/34 (61.8) 13/34 (38.2) 7/34 (20.6) 6/34 (17.6)
10–50 22/40 (55.0) 18/40 (45.0) 9/40 (22.5) 9/40 (22.5)
.50 12/17 (70.6) 5/17 (29.4) 3/17 (17.6) 2/17 (11.8)
p for difference 0.53 0.92 0.62
Age at the first homosexual act
,18 11/14 (78.6) 3/14 (21.4) 2/14 (14.3) 1/14 (7.14)
$18 48/81 (59.3) 33/81 (40.7) 17/81 (21.0) 16/81 (19.8)
p for difference 0.17 0.73 0.45
Is anal sex a regular homosexual behavior?
No 8/11 (72.7)) 3/11 (27.3) 0/11 (0) 3/11 (27.3)
Yes 51/84 (60.7) 33/84 (39.3) 19/84 (22.6) 14/84 (16.7)
p for difference 0.53 0.11 0.41
Is receptive anal sex a regular homosexual behavior?
No 37/53 (69.8) 16/53 (30.2) 7/53 (13.2) 9/53 (17.0)
Yes 22/42 (52.4) 20/42 (47.6) 12/42 (28.6) 8/42 (19.0)
p for difference 0.08 0.06 0.79
Is insertive anal sex a regular homosexual behavior?
No 30/52 (57.7) 22/52 (42.3) 12/52 (23.1) 10/52 (19.2)
Yes 29/43 (67.4) 14/43 (32.6) 7/43 (16.3) 7/43 (16.3)
p for difference 0.33 0.41 0.71
Is oral sex a regular homosexual behavior?
No 3/6 (50.0) 3/6 (50.0) 1/6 (16.7) 2/6 (33.3)
Yes 56/89 (62.9) 33/89 (37.1) 18/89 (20.2) 15/89 (16.9)
p for difference 0.67 1.00 0.29
Is anilinction a regular homosexual behavior?
No 44/68 (64.7) 24/68 (35.3) 12/68 (17.6) 12/68 (17.6)
Yes 15/27 (55.6) 12/27 (44.4) 7/27 (25.9) 5/27 (18.5)
p for difference 0.41 0.36 1.00
Frequency of homosexual behaviors in the past 6 months
,once a week 48/77 (62.3) 29/77 (37.7) 15/77 (19.5) 14/77 (18.2)
$once a week 10/17 (58.8) 7/17 (41.2) 4/17 (23.5) 3/17 (17.6)
p for difference 0.79 0.74 1.00
Abbreviation: ASCUS=atypical squamous cells of undetermined significance; ASC-H=atypical squamous cells but cannot exclude HSIL; ASIL=anal squamous
intraepithelial lesions, include low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL); HIV=human immunodeficiency
virus; STD=sexually transmitted diseases.
*Sum may not always add up to total because of missing data.
doi:10.1371/journal.pone.0035983.t003
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To our knowledge, this pilot study was the first investigation into
the prevalence of HPV genotypes in HIV-infected MSM with
abnormal anal cytology in China. Based on a cross-sectional study
design, a total of 95 HIV-infected MSM were included in the
study, 36 of them (37.9%) showed abnormal anal cytology
including 17 with ASIL/ASC-H (17.9%). Different HPV genotype
distributions were found between patients with normal and
abnormal anal cytology. Infection of multiple HPV types and
high-risk types were found to be associated with an increased risk
of abnormal anal cytology.
Invasive anal cancer has well-documented precursors, known as
HSIL (cytology) or AIN2/3 (histology) [22]. LSIL and AIN 1 are
not considered to be direct precursors of invasive anal cancer, but
may precede the later development of HSIL or AIN2/3.
Therefore, ASIL, which include LSIL and HSIL, was considered
as AIN to predict the presence of anal dysplasia. Palefsky JM and
colleagues reported the prevalence of AIN2/3 as 52% in 81 HIV-
positive MSM participants from US in 2005 [23]. In 2010, Salit IE
and colleges assessed the prevalence of abnormal anal cytology
based on a cross-sectional study of 401 HIV-positive MSM from
Canada. They found cytology was abnormal in 67% of patients:
HSIL, 12%; LSIL, 43% and ASC-US, 12% [24]. In addition,
Table 4. Association between sexual factors and abnormal anal cytology among study participants.
Variables
Normal n/N *
(%) Abnormal
Total n/N* (%)
ASCUS
n/N* (%)
ASIL/ASC-H n/N*
(%)
Number of partners with oral sex in the past 6 months
#2 22/38 (57.9) 16/38 (42.1) 6/38 (15.8) 10/38 (26.3)
.2 13/18 (72.2) 5/18 (27.8) 5/18 (27.8) 0/18 (0)
p for difference 0.30 0.31 0.02
Condom use during oral sex in the past 6 months
Always 6/11 (54.5) 5/11 (45.5) 2/11 (18.2) 3/11 (27.3)
Sometimes/Never 29/45 (64.4) 16/45 (35.6) 9/45 (20.0) 7/45 (15.6)
p for difference 0.73 1.00 0.40
Number of partners with insertive sex in the past 6 months
#2 19/31 (61.3) 12/31 (38.7) 8/31 (25.8) 4/31 (12.9)
.2 11/14 (78.6) 3/14 (21.4) 2/14 (14.3) 1/14 (7.1)
p for difference 0.32 0.47 1.00
Condom use during insertive anal sex in the past 6 months
Always 27/39 (69.2) 12/39 (30.8) 8/39 (20.5) 4/39 (10.3)
Sometimes/Never 5/7 (71.4) 2/7 (28.6) 1/7 (14.3) 1/7 (14.3)
p for difference 1.00 1.00 1.00
Number of partners with receptive anal sex in the past 6 months
#2 19/34 (55.9) 15/34 (44.1) 6/34 (17.6) 9/34 (26.5)
.2 14/18 (77.8) 4/18 (22.2) 4/18 (22.2) 0/18 (0)
p for difference 0.12 0.73 0.02
Condom use during receptive anal sex in the past 6 months
Always 28/46 (60.9) 18/46 (39.1) 10/46 (21.7) 8/46 (17.4)
Sometimes/Never 7/8 (87.5) 1/8 (12.5) 0/8 (0) 1/8 (12.5)
p for difference 0.24 0.33 1.00
Have received anilinction in the past 6 months
No 54/84 (64.3) 30/84 (35.7) 15/84 (17.9) 15/84 (17.9)
Yes 5/11 (45.5) 6/11 (54.5) 4/11 (36.4) 2/11 (18.2)
p for difference 0.32 0.22 1.00
Syphilis infection
#
Negative 31/49 (63.3) 18/49 (36.7) 8/49 (16.3) 10/49 (20.4)
Positive 28/46 (60.9) 18/46 (39.1) 11/46 (23.9) 7/46 (15.2)
p for difference 0.81 0.36 0.51
Abbreviation: ASCUS=atypical squamous cells of undetermined significance; ASC-H=atypical squamous cells but cannot exclude HSIL; ASIL=anal squamous
intraepithelial lesions, include low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL).
*Sum may not always add up to total because of missing data.
#Syphilis positivity was determined through screening by a positive rapid-plasma reagin test and confirmation by an Enzyme-linked immunosorbent assay for detection
of antibodies to Treponema pallidum.
doi:10.1371/journal.pone.0035983.t004
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and high-resolution anoscopy (HRA) in the baseline screening of a
cohort study with 247 HIV- seropositive MSM, the anal abnormal
cytology results were ASCUS, 33%; LSIL, 26%; HSIL, 6%, while
HRA findings were AIN1, 50%; AIN2, 17% AIN3, 13% [25]. In
Asians, Li AH and colleagues reported the prevalence of anal
abnormal cytology among HIV positive MSM in in Thailand:
16.1% had ASC-US, 14.4% had LSIL and 3.4% had HSIL [26].
In our present study, the prevalence of abnormal anal cytology
was 37.9%: ASC-US, 20.0%; LSIL, 15.8%; HSIL, 1.1%. Our
results were very close to the data from Thailand but not the data
from US and Canada especially with respect to the prevalence of
HSIL. While it is difficult to directly compare the results from
different studies due to the various characteristics of the study
participants including age, stage of disease, status of immune
system, and history of HAART. As reported, current CD4 cell
count, CD4 cell count at beginning of HAART and duration of
HAART might influence risks of AIN2/3 among HIV-infected
MSM [25]. Consistently, our results also observed increased
prevalence of normal anal cytology among those with higher
current CD4 cell count (p for trend=0.04). Despite of the
heterogeneity between studies, it is consistent that abnormal anal
cytology is common in MSM with HIV infection. Considering
anal cancer risk in this population is present and increasing, anal
screening could prove to be important [27]. Although anal
cytology testing is currently imperfect with low specificity, it is still
a useful tool in identifying high-risk patients with HIV infection in
regions with limited clinical resources. In addition, it also provides
an important support for the study addressing the impact of
specific HPV types during the development of anal cancer.
In the past decade, multiple studies have reported that anal
HPV infection is common among MSM especially in HIV-
infected MSM [6,28–30]. In our previous study, the prevalence of
HPV infection was reported as 96% in newly diagnosed HIV-
infected Chinese MSM [19]. In the present study the prevalence of
HPV infection was 70.3%. Considering 30.5% of study partici-
pants were receiving HAART and only 7.4% of them with low
CD4 cell counts less than 200 cells/mL of blood, the negative
Table 5. HPV genotypes and abnormal anal cytology among study participants.
HPV infection Normal (N*=55) n (%) Abnormal
Total (N=36) n (%) ASCUS (N=19) n (%) ASIL/ASC-H (N=17) n (%)
Total
Any type 36 (65.5) 28 (77.8) 14 (73.7) 14 (82.4)
Single type 25 (45.5) 12 (33.3) 6 (31.6) 6 (35.3)
Multiple type 11 (20.0) 16 (44.4) 8 (42.1) 8 (47.1)
High-risk types
HPV16 6 (10.9) 7 (19.4) 5 (26.3) 2 (11.8)
HPV18 3 (5.5) 4 (11.1) 1 (5.3) 3 (17.6)
HPV31 1 (1.8) 1 (2.8) 1 (5.3) 0 (0)
HPV33 1 (1.8) 0 (0) 0 (0) 0 (0)
HPV35 0 (0) 0 (0) 0 (0) 0 (0)
HPV39 5 (9.1) 3 (8.3) 1 (5.3) 2 (11.8)
HPV45 2 (3.6) 6 (16.7) 2 (10.5) 4 (23.5)
HPV51 0 (0) 0 (0) 0 (0) 0 (0)
HPV52 5 (9.1) 6 (16.7) 2 (10.5) 4 (23.5)
HPV56 6 (10.9) 3 (8.3) 1 (5.3) 2 (11.8)
HPV58 0 (0) 1 (2.8) 0 (0) 1 (5.9)
HPV59 1 (1.8) 2 (5.6) 2 (10.5) 0 (0)
HPV66 2 (3.6) 0 (0) 0 (0) 0 (0)
HPV68 4 (7.3) 3 (8.3) 1 (5.3) 2 (11.8)
HPV82 2 (3.6) 3 (8.3) 2 (10.5) 1 (5.9)
HPV83 0 (0) 0 (0) 0 (0) 0 (0)
HPV53 0 (0) 0 (0) 0 (0) 0 (0)
HPV26/55 1 (1.8) 2 (5.6) 2 (10.5) 0 (0)
Low-risk types
HPV06 11 (20.0) 7 (19.4) 3 (15.8) 4 (23.5)
HPV11 3 (5.5) 3 (8.3) 1 (5.3) 2 (11.8)
HPV40/42/44 1 (1.8) 0 (0) 0 (0) 0 (0)
HPV61/73 0 (0) 1 (2.8) 1 (5.3) 0 (0)
Abbreviation: ASCUS=atypical squamous cells of undetermined significance; ASC-H=atypical squamous cells but cannot exclude HSIL; ASIL=anal squamous
intraepithelial lesions, include low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL); HPV=human papillomavirus.
*Four study participants were not included in this analysis due to missing data on HPV genotypes.
doi:10.1371/journal.pone.0035983.t005
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be a possible explanation to the observed lower HPV prevalence
[31]. In addition, although it has been consistently reported that
HAART had little effect on ASIL and anal cancer in HIV-infected
MSM [32,33], the role of HAART on the natural history of anal
HPV infection including clearance and acquisition is still not clear
[20,32]. Studies with larger sample sizes are needed to address this
important issue and to explore ways of controlling HPV infection
and related disease in patients with HIV infection. Consistent with
previous reports, multiple HPV type infection was common in our
study participants, HPV multiplicity and high-risk HPV types were
associated with increased risks of ASIL. Among those with
abnormal anal cytology, the most common high-risk types were
found to be HPV16 (19.4%), HPV45 (16.7%), HPV52 (16.7%)
and HPV18 (11.1%) [32]. In a recently published article from
Germany, it was reported that the most common high-risk HPV
types were HPV16 (72.5%), HPV18 (25%) and HPV68 (12.5%) in
HIV-infected MSM with HSIL [34]. The different prevalence and
distribution of HPV subtypes in different study populations should
be given exclusive attention, because it might reflect various
geographic distribution of the genotypes or heterogeneous host
susceptibility to the pathogens. This important issue is also crucial
for the development of specific prevention strategies including
vaccine. In addition, the different prevalence of HPV types might
contribute to, at least in part, the lower prevalence of HSIL (1.1%)
observed in our study as well. Further studies with large sample
size are needed to verify these important postulations.
Some limitations of this study should be considered. First, HRA
needs more advanced medical recourses especially for HIV-
infected patients [8], to our knowledge, no hospital provides HRA
for HIV infections in China currently. As recently reported [35],
in HIV-infected MSM, the direct use of HRA is the most cost-
effective strategy for detecting AIN 2/3. However, the higher cost
per use for HRA was offset by the high sensitivity and low
specificity of HPV and cytology testing. Therefore, the major aim
of this pilot study focused on the investigation of the association
between HPV prevalence and abnormal anal cytology. At the
present time, we are trying to set up HRA for HIV-infected MSM
under cooperation with infectious diseases hospital which would
be much helpful for anal cancer screening among HIV-infected
MSM. Second, with respect to the observed extremely lower
prevalence of HSIL (1.1%) as compare to the previous reports
(6%–12%) [24,25], the potential misclassification of anal cytology
in our study could not be completely excluded. The techniques of
cervical cytology has been mature in China, however, training for
anal cytologist still should be strengthened in China. Third, socio-
demographic data and risk behaviors were based on an interview
using a standardized questionnaire which is open to recall and
information bias. Forth, the small sample size of this pilot study
limited further analysis, and potential selection bias cause by the
used sampling method should be kept in mind as well when
interpreting the prevalence data.
In conclusion, the high prevalence of HPV infection and
abnormal anal cytology was observed among HIV-infected MSM
in China. Infection of multiple HPV types and high-risk types were
found to be associated with an increased risk of abnormal anal
cytology. Considering the high prevalence of HIV infection in this
high-risk population in China, more studies addressing anal HPV
infection and related diseases in HIV-infected MSM are needed.
Materials and Methods
Ethic review
The study was approved by the Ethics Committee of the
Institute of Pathogen Biology, Chinese Academy of Medical
Sciences & Peking Union Medical College. Written informed
consent was obtained from each study participant before the
interview, sample collection and testing.
Study population
Study participants were outpatients of the Capital City
Dermatology Hospital and were recruited through local MSM
nongovernment organization (Beijing Rainbow Volunteers Work-
station) between January and April 2011. To maximize outreach
of study information to HIV-infected MSM community, multiple
methods were used for recruitment including MSM website
advertisement, distributing flyers with study-related information at
MSM-frequented venues (e.g., MSM clubs, bars, parks and
bathhouses), and participants were also encouraged to refer their
friends and acquaintances to attend the study. Those eligible to
Table 6. Association of abnormal anal cytology and HPV genotypes among study participants.
Anal infection of 26 HPV
types
Abnormal/
Normal
Adjusted OR
*
(95% CI)
ASCUS/
Normal
Adjusted OR
* (95%
CI) (ASIL/ASC-H)/Normal Adjusted OR
* (95% CI)
High-Risk types infection
Negative for high-risk types10/26 Ref. 6/26 Ref. 4/26 Ref.
Positive for high-risk types 26/29 2.02 (0.77–5.29) 13/29 1.63 (0.49–5.43) 13/29 2.48 (0.68–9.00)
p for difference 0.15 0.43 0.17
By multiplicity of HPV
types
0 8/19 Ref. 5/19 Ref. 3/19 Ref.
1 12/25 1.22 (0.40–3.72) 6/25 0.83 (0.20–3.41) 6/25 1.71 (0.36–8.02)
2 9/7 3.81 (1.00–14.61) 5/7 4.08 (0.79–21.11) 4/7 4.71 (0.77–28.61)
$3 7/4 4.71 (1.02–21.76) 3/4 2.71(0.41–17.82) 4/4 7.49 (1.07–52.21)
p for trend 0.04 0.20 0.04
Abbreviation: ASCUS=atypical squamous cells of undetermined significance; ASC-H=atypical squamous cells but cannot exclude HSIL; ASIL=anal squamous
intraepithelial lesions, include low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL); CI=confidence intervals;
HPV=human papillomavirus; OR=odds ratio.
*Adjusted for age, education, age at the first homosexual act, frequency of homosexual behaviors in the past 6 months and ever found sexual partners in gay venues.
doi:10.1371/journal.pone.0035983.t006
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homosexual behaviors, willing to take tests for anal HPV infection
and anal cytology, and provision of written informed consent. The
presence or absence of any symptoms, including anal symptoms,
did not influence eligibility. Study participants who were positive
for suspicious symptoms related to STD (purulent secretion, rash,
ulcer, pain, abnormal outgrowth and pruritus on the penis or
crissum) and abnormal cytology were informed by study personnel
in private and referred to the Capital City Dermatology Hospital
or the Beijing Cancer Hospital for further diagnosis and treatment.
Data collection
Sociodemographic and sexual behavior data were collected
using one-to-one interviews in a separate room and a standardized
questionnaire. The content of the questionnaire includes self-
reported sociodemographic characteristics (e.g., age, income,
ethnicity, education, employment, and marriage status), regular
homosexual behavior, sexual behaviors in the past 6 months,
status of HIV infection and treatment, knowledge on STD, history
of STD, and lifestyle factors (i.e. current drinking status, history of
drug abuse and injection drug use). As explained to the
participants, regular homosexual behavior was defined as at least
50% of sexual activities occurring with males. Each study
participant was assigned a unique code that was used to link the
questionnaire and specimens. Personal contact information, which
was blinded to researchers, was kept by the Beijing Rainbow
Volunteers Workstation for test results feedback and data
validation.
Cytological analysis and HPV DNA typing
Trained personnel collected anal samples for cytological analysis
and HPV typing by rotating a saline water moistened nylon
flocked swab in the anal canal for about 2 minutes. The
cytological specimens were then placed on a glass slide and
stained with a Papanicolaou’s stain. The cytology slides were read
by a cytologist from Hospital of Cancer, Chinese Academy of
Medical Sciences and Peking Union Medical College (Dr. Zhihui
Zhang). Using the Bethesda system criteria for evaluation of
cervical cytological results [36], the anal cytological results were
classified as normal and abnormal. Abnormal results were further
classified as ASC-US, ASC-H, LSIL and HSIL [37]. Smears were
classified as unsatisfactory if no epithelial cells were present. After
cytological samples have been collected, the swab was then kept in
a 3 mL sample transport medium of the Tellgenplex
TM HPV
DNA Test (Tellgen Life Science, Shanghai, China). Tellgen-
plex
TM HPV DNA Test is based on suspension bead array method
to identify HPV types. Suspension bead array is a technical based
on PCR, beads coated hybridization, flow cytometry, lasers and
digital signal processing. Target HPV DNA-specific probes can be
coated on the surface of spectrally addressable polystyrene beads.
As the beads are internally labeled with a ratio of two spectrally
distinct fluorophores, the bead lots are assignable to class-specific
HPV subtypes. Mixtures of different bead suspensions can be used
in the same well of a 96-well plate format allowing for multiplex
analysis. Tellgenplex
TM HPV DNA Test provides identification of
19 recommended high-risk subtypes (16, 18, 26, 31, 33, 35, 39, 45,
51, 52, 53, 55, 56, 58, 59, 66, 68, 82, and 83) which are associated
with cervical cancer. Besides that, the kit also provides detection of
7 low-risk subtypes (6, 11, 40, 42, 44, 61, and 73). The tests were
performed by Xiangwei Li and Yu Yang in the laboratory located
in the institute of Pathogen Biology as described in elsewhere [19].
Statistical analysis
Double entered questionnaires and laboratory results were
analyzed using Statistical Analysis System (SAS 9.2 for Windows;
SAS Institute Inc., NC, USA). The study population was described
by age, ethnicity, education, marriage status, age at the first
homosexual act, number of homosexual partners ever had, status
of syphilis, ever had STD other than HIV, had receipted HAART,
latest CD4 cell count (tested in the recent three months), time since
HIV diagnosis, regular sex behavior (anal sex, receptive anal sex,
insertive anal sex, oral sex, anilinction), number of partners in the
past six months and condom use during these activities.
Differences between groups were assessed using Pearson chi-
square or Fisher exact test.
The associations of potential risk factors with HPV infection
and anal cytological results were estimated by means of OR and
95% confidence intervals (CI) using logistic regression analysis.
Covariates with a significant association in the univariate analyses
were included the following multivariate analysis using a
significance level of 0.05. In order to investigate the combined
effect of HPV types, the risk of anal cytological results was then
assessed with respect to the HPV subgroups according to
carcinogenicity and the number of HPV types in each sample.
Tests for trend by were performed by treating categories of the
number as continuous variable in the logistic regression analysis.
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